ATP6V0D1 Human 1,2-dimethylhydrazine multiple interactions ISO Atp6v0d1 (Mus musculus) 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP6V0D1 mRNA CTD PMID:22206623 ATP6V0D1 Human 14-Deoxy-11,12-didehydroandrographolide decreases expression EXP 6480464 14-deoxy-11,12-didehydroandrographolide results in decreased expression of ATP6V0D1 mRNA CTD PMID:22101062 ATP6V0D1 Human 17alpha-ethynylestradiol decreases expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of ATP6V0D1 mRNA CTD PMID:17108234 ATP6V0D1 Human 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Atp6v0d1 (Mus musculus) 6480464 2,2',4,4'-tetrabromodiphenyl ether affects the expression of ATP6V0D1 mRNA CTD PMID:30294300 ATP6V0D1 Human 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO Atp6v0d1 (Mus musculus) 6480464 [Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of more ... CTD PMID:38995820 ATP6V0D1 Human 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO Atp6v0d1 (Mus musculus) 6480464 2,3',4,4',5-pentachlorobiphenyl results in increased expression of ATP6V0D1 mRNA CTD PMID:31388691 ATP6V0D1 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Atp6v0d1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP6V0D1 mRNA CTD PMID:19933214 ATP6V0D1 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP6V0D1 mRNA CTD PMID:33387578 ATP6V0D1 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of ATP6V0D1 mRNA CTD PMID:34747641 ATP6V0D1 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Atp6v0d1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ATP6V0D1 mRNA CTD PMID:21570461 ATP6V0D1 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP6V0D1 mRNA CTD PMID:20106945|PMID:21632981 ATP6V0D1 Human 2,4-dinitrotoluene affects expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 2,4-dinitrotoluene affects the expression of ATP6V0D1 mRNA CTD PMID:21346803 ATP6V0D1 Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 ATP6V0D1 Human 4,4'-sulfonyldiphenol increases expression ISO Atp6v0d1 (Mus musculus) 6480464 bisphenol S results in increased expression of ATP6V0D1 mRNA CTD PMID:39298647 ATP6V0D1 Human 4,4'-sulfonyldiphenol affects expression EXP 6480464 bisphenol S affects the expression of ATP6V0D1 protein CTD PMID:31945527 ATP6V0D1 Human acetylsalicylic acid decreases expression EXP 6480464 Aspirin results in decreased expression of ATP6V0D1 mRNA CTD PMID:15928584 ATP6V0D1 Human aconitine increases expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 Aconitine results in increased expression of ATP6V0D1 protein CTD PMID:33236894 ATP6V0D1 Human acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268|PMID:32845096 ATP6V0D1 Human acrylamide increases expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 Acrylamide results in increased expression of ATP6V0D1 mRNA CTD PMID:28959563 ATP6V0D1 Human aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of ATP6V0D1 intron CTD PMID:30157460 ATP6V0D1 Human aflatoxin B1 multiple interactions EXP 6480464 [Aflatoxin B1 co-treated with beta-Naphthoflavone] results in increased expression of ATP6V0D1 protein CTD PMID:39638853 ATP6V0D1 Human all-trans-retinoic acid multiple interactions EXP 6480464 [Tretinoin co-treated with arsenic trioxide] results in increased expression of ATP6V0D1 mRNA CTD PMID:15894607 ATP6V0D1 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of ATP6V0D1 mRNA CTD PMID:15894607|PMID:33167477 ATP6V0D1 Human alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268 ATP6V0D1 Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of ATP6V0D1 mRNA CTD PMID:33212167 ATP6V0D1 Human arsane affects methylation EXP 6480464 Arsenic affects the methylation of ATP6V0D1 gene CTD PMID:25304211 ATP6V0D1 Human arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of ATP6V0D1 gene CTD PMID:25304211 ATP6V0D1 Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of ATP6V0D1 mRNA CTD PMID:29307831 ATP6V0D1 Human arsenous acid multiple interactions EXP 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ATP6V0D1 mRNA; Acetylcysteine inhibits the more ... CTD PMID:15894607|PMID:29307831 ATP6V0D1 Human azoxystrobin multiple interactions ISO Atp6v0d1 (Rattus norvegicus) 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... CTD PMID:33854195 ATP6V0D1 Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of ATP6V0D1 promoter CTD PMID:27901495 ATP6V0D1 Human benzo[e]pyrene decreases methylation EXP 6480464 benzo(e)pyrene results in decreased methylation of ATP6V0D1 intron CTD PMID:30157460 ATP6V0D1 Human beta-lapachone increases expression EXP 6480464 beta-lapachone results in increased expression of ATP6V0D1 mRNA CTD PMID:38218311 ATP6V0D1 Human beta-naphthoflavone decreases expression EXP 6480464 beta-Naphthoflavone results in decreased expression of ATP6V0D1 protein CTD PMID:39638853 ATP6V0D1 Human beta-naphthoflavone multiple interactions EXP 6480464 [Aflatoxin B1 co-treated with beta-Naphthoflavone] results in increased expression of ATP6V0D1 protein CTD PMID:39638853 ATP6V0D1 Human bisphenol A increases expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of ATP6V0D1 mRNA CTD PMID:25181051 ATP6V0D1 Human bisphenol A increases expression ISO Atp6v0d1 (Mus musculus) 6480464 bisphenol A results in increased expression of ATP6V0D1 mRNA CTD PMID:33221593 ATP6V0D1 Human bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ATP6V0D1 mRNA; bisphenol A results in increased expression more ... CTD PMID:29275510|PMID:33376534|PMID:37567409 ATP6V0D1 Human bisphenol AF increases expression EXP 6480464 bisphenol AF results in increased expression of ATP6V0D1 protein CTD PMID:34186270 ATP6V0D1 Human Bisphenol B increases expression EXP 6480464 bisphenol B results in increased expression of ATP6V0D1 protein CTD PMID:34186270 ATP6V0D1 Human bisphenol F multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 ATP6V0D1 Human Brodifacoum increases expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 bromfenacoum results in increased expression of ATP6V0D1 protein CTD PMID:28903499 ATP6V0D1 Human C60 fullerene decreases expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 fullerene C60 results in decreased expression of ATP6V0D1 mRNA CTD PMID:19167457 ATP6V0D1 Human cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP6V0D1 more ... CTD PMID:31319114 ATP6V0D1 Human cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP6V0D1 more ... CTD PMID:31319114 ATP6V0D1 Human cadmium dichloride increases expression ISO Atp6v0d1 (Mus musculus) 6480464 Cadmium Chloride results in increased expression of ATP6V0D1 mRNA CTD PMID:30030080 ATP6V0D1 Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of ATP6V0D1 mRNA CTD PMID:38568856 ATP6V0D1 Human captan increases expression ISO Atp6v0d1 (Mus musculus) 6480464 Captan results in increased expression of ATP6V0D1 mRNA CTD PMID:31558096 ATP6V0D1 Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of ATP6V0D1 mRNA CTD PMID:25979313 ATP6V0D1 Human carbon nanotube increases expression ISO Atp6v0d1 (Mus musculus) 6480464 Nanotubes, Carbon analog results in increased expression of ATP6V0D1 mRNA CTD PMID:25554681 ATP6V0D1 Human chlorpyrifos multiple interactions ISO Atp6v0d1 (Rattus norvegicus) 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... CTD PMID:33854195 ATP6V0D1 Human chlorpyrifos increases expression ISO Atp6v0d1 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of ATP6V0D1 mRNA CTD PMID:37019170 ATP6V0D1 Human clofibrate decreases expression ISO Atp6v0d1 (Mus musculus) 6480464 Clofibrate results in decreased expression of ATP6V0D1 mRNA CTD PMID:17585979 ATP6V0D1 Human copper atom decreases expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 Copper results in decreased expression of ATP6V0D1 mRNA CTD PMID:22465980 ATP6V0D1 Human copper atom multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of ATP6V0D1 mRNA CTD PMID:24690739 ATP6V0D1 Human copper atom multiple interactions ISO Atp6v0d1 (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression more ... CTD PMID:15467011 ATP6V0D1 Human copper(0) decreases expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 Copper results in decreased expression of ATP6V0D1 mRNA CTD PMID:22465980 ATP6V0D1 Human copper(0) multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of ATP6V0D1 mRNA CTD PMID:24690739 ATP6V0D1 Human copper(0) multiple interactions ISO Atp6v0d1 (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression more ... CTD PMID:15467011 ATP6V0D1 Human dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 ATP6V0D1 Human dextran sulfate multiple interactions ISO Atp6v0d1 (Mus musculus) 6480464 evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ATP6V0D1 protein] CTD PMID:35362542 ATP6V0D1 Human dextran sulfate increases expression ISO Atp6v0d1 (Mus musculus) 6480464 Dextran Sulfate results in increased expression of ATP6V0D1 protein CTD PMID:35362542 ATP6V0D1 Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of ATP6V0D1 mRNA CTD PMID:29307831 ATP6V0D1 Human diarsenic trioxide multiple interactions EXP 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ATP6V0D1 mRNA; Acetylcysteine inhibits the more ... CTD PMID:15894607|PMID:29307831 ATP6V0D1 Human disulfiram multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of ATP6V0D1 mRNA CTD PMID:24690739 ATP6V0D1 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 ATP6V0D1 Human doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of ATP6V0D1 mRNA CTD PMID:29803840 ATP6V0D1 Human elemental selenium increases expression EXP 6480464 Selenium results in increased expression of ATP6V0D1 mRNA CTD PMID:19244175 ATP6V0D1 Human ethanol increases expression ISO Atp6v0d1 (Mus musculus) 6480464 Ethanol results in increased expression of ATP6V0D1 mRNA CTD PMID:30319688 ATP6V0D1 Human ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of ATP6V0D1 mRNA CTD PMID:23649840 ATP6V0D1 Human Evodiamine multiple interactions ISO Atp6v0d1 (Mus musculus) 6480464 evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ATP6V0D1 protein] CTD PMID:35362542 ATP6V0D1 Human folic acid multiple interactions ISO Atp6v0d1 (Mus musculus) 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP6V0D1 mRNA CTD PMID:22206623 ATP6V0D1 Human formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of ATP6V0D1 mRNA CTD PMID:23649840 ATP6V0D1 Human gentamycin increases expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of ATP6V0D1 mRNA CTD PMID:33387578 ATP6V0D1 Human glycochenodeoxycholic acid decreases expression EXP 6480464 Glycochenodeoxycholic Acid results in decreased expression of ATP6V0D1 mRNA CTD PMID:32439580 ATP6V0D1 Human glyphosate multiple interactions ISO Atp6v0d1 (Rattus norvegicus) 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... CTD PMID:33854195 ATP6V0D1 Human imidacloprid multiple interactions ISO Atp6v0d1 (Rattus norvegicus) 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... CTD PMID:33854195 ATP6V0D1 Human indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 ATP6V0D1 Human indometacin decreases expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 Indomethacin results in decreased expression of ATP6V0D1 mRNA CTD PMID:36868495 ATP6V0D1 Human isoniazide increases expression EXP 6480464 Isoniazid results in increased expression of ATP6V0D1 protein CTD PMID:40015660 ATP6V0D1 Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of ATP6V0D1 protein CTD PMID:32959892 ATP6V0D1 Human methapyrilene decreases methylation EXP 6480464 Methapyrilene results in decreased methylation of ATP6V0D1 intron CTD PMID:30157460 ATP6V0D1 Human methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of ATP6V0D1 mRNA CTD PMID:23649840 ATP6V0D1 Human N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in more ... CTD PMID:29307831|PMID:31319114 ATP6V0D1 Human osimertinib increases expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 osimertinib results in increased expression of ATP6V0D1 protein CTD PMID:38734218 ATP6V0D1 Human ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268|PMID:32845096 ATP6V0D1 Human rifampicin multiple interactions EXP 6480464 ATP6V0D1 protein affects the reaction [Rifampin inhibits the reaction [Rotenone results in increased lipidation of more ... CTD PMID:31648047 ATP6V0D1 Human rotenone increases expression EXP 6480464 Rotenone results in increased expression of ATP6V0D1 mRNA; Rotenone results in increased expression of ATP6V0D1 more ... CTD PMID:31648047|PMID:39603559 ATP6V0D1 Human rotenone multiple interactions EXP 6480464 ATP6V0D1 protein affects the reaction [Rifampin inhibits the reaction [Rotenone results in increased lipidation of more ... CTD PMID:31648047 ATP6V0D1 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 ATP6V0D1 Human selenium atom increases expression EXP 6480464 Selenium results in increased expression of ATP6V0D1 mRNA CTD PMID:19244175 ATP6V0D1 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ATP6V0D1 mRNA CTD PMID:38568856 ATP6V0D1 Human sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of ATP6V0D1 mRNA CTD PMID:31533062 ATP6V0D1 Human temozolomide decreases expression EXP 6480464 Temozolomide results in decreased expression of ATP6V0D1 mRNA CTD PMID:31758290 ATP6V0D1 Human thiabendazole multiple interactions ISO Atp6v0d1 (Rattus norvegicus) 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... CTD PMID:33854195 ATP6V0D1 Human thioacetamide decreases expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of ATP6V0D1 mRNA CTD PMID:34492290 ATP6V0D1 Human thiram increases expression EXP 6480464 Thiram results in increased expression of ATP6V0D1 mRNA CTD PMID:38568856 ATP6V0D1 Human titanium dioxide increases methylation ISO Atp6v0d1 (Mus musculus) 6480464 titanium dioxide results in increased methylation of ATP6V0D1 gene CTD PMID:35295148 ATP6V0D1 Human titanium dioxide decreases methylation ISO Atp6v0d1 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of ATP6V0D1 gene; titanium dioxide results in decreased methylation more ... CTD PMID:35295148 ATP6V0D1 Human trichostatin A affects expression EXP 6480464 trichostatin A affects the expression of ATP6V0D1 mRNA CTD PMID:28542535 ATP6V0D1 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of ATP6V0D1 mRNA CTD PMID:37042841 ATP6V0D1 Human Triptolide increases expression ISO Atp6v0d1 (Rattus norvegicus) 6480464 triptolide results in increased expression of ATP6V0D1 protein CTD PMID:32519852 ATP6V0D1 Human urethane increases expression EXP 6480464 Urethane results in increased expression of ATP6V0D1 mRNA CTD PMID:28818685 ATP6V0D1 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of ATP6V0D1 mRNA CTD PMID:25979313 ATP6V0D1 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of ATP6V0D1 mRNA CTD PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386|PMID:28001369 ATP6V0D1 Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 ATP6V0D1 Human vitamin E increases expression EXP 6480464 Vitamin E results in increased expression of ATP6V0D1 mRNA CTD PMID:19244175 ATP6V0D1 Human Yessotoxin increases expression EXP 6480464 yessotoxin analog results in increased expression of ATP6V0D1 mRNA CTD PMID:30679557